Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
09/2003
09/25/2003US20030180707 Recombinant expression construct encoding a reporter gene operably linked to a promoter from a gene the expression of which is induced by a retinoid, wherein the promoter does not contain a retinoic acid response elements site
09/25/2003US20030180406 Treatment of diseases involving defective gap junctional communication
09/25/2003US20030180389 Effervescent glucosamine, chondroitin and MSM formula
09/25/2003US20030180383 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents
09/25/2003US20030180382 Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease
09/25/2003US20030180366 Bioadhesive drug delivery system
09/25/2003US20030180358 Controlled release
09/25/2003US20030180357 Core with coating; water soluble dye in matrix as core; gellan gum coatings; easier detection of tablet
09/25/2003US20030180355 Combination therapy for hypertension
09/25/2003US20030180348 Transcellular drug delivery system
09/25/2003US20030180339 Topical treatment of skin
09/25/2003US20030180319 Mutant bacteriophages; genetic engineering
09/25/2003US20030180317 Diagnosis ear infections in children
09/25/2003US20030180301 Prevention organ rejection; induction immunology response; reduce fibrosis
09/25/2003US20030180300 Collagen biosynthesis; controlling cell differentiation, cell proliferation
09/25/2003US20030180296 Antibodies that immunospecifically bind to trail receptors
09/25/2003US20030180295 Angiocidin: a Cys-Ser-Val-Thr-Cys-Gly specific tumor cell adhesion receptor
09/25/2003US20030180294 Administering vascular endothelial growth factor receptor inhibitor; supression lymphangiogenesis
09/25/2003US20030180285 Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti hsp90 antibodies
09/25/2003US20030180282 Method of treatment of thrombotic events
09/25/2003US20030180279 Composition and method to prevent or reduce diarrhea and steatorrhea in HIV patients
09/25/2003US20030180265 Modulating angiogenesis
09/25/2003US20030180260 Immunotherapy or treating bacterial or viral infection at mucosal surfaces with probiotics, and compositions therefor
09/25/2003US20030180253 Stabilized liquid polypeptide-containing pharmaceutical compositions
09/25/2003US20030180246 Free-flowing anionic surfactant, alkanolamide and electrolytemixture
09/25/2003CA2519623A1 Increasing tumor oxygen content by administration of stressed cells
09/25/2003CA2518794A1 Compositions and methods for treating emphysema
09/25/2003CA2479350A1 Ne and 5-ht reuptake inhibitors for treating visceral pain syndromes
09/25/2003CA2479266A1 Azetidine derivatives as ccr-3 receptor antagonists
09/25/2003CA2479151A1 Use of proton pump inhibitors for the treatment of noncardiac chest pain
09/25/2003CA2479098A1 Methods and compositions comprising nitric oxide donors and opioid analgesics
09/25/2003CA2478997A1 Use of copper chelating tetraamines for the treatment of cardiovascular disease and heart failure
09/25/2003CA2478965A1 Agents for corneal or intrastromal administration to treat or prevent disorders of the eye
09/25/2003CA2478808A1 Use of asc-1 inhibitors to treat neurological and psychiatric disorders
09/25/2003CA2478760A1 Use of enzyme inhibitors with aminopeptidase n and/or dipeptidylpeptidase iv activities and pharmaceutical preparations produced therefrom for the therapy and prevention of dermatological diseases with seborrhoeic hyperproliferation and altered differentiation states
09/25/2003CA2478731A1 Carbamates as hiv protease inhibitors
09/25/2003CA2478310A1 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamides useful as hiv integrase inhibitors
09/25/2003CA2478211A1 Nk1 antagonists
09/25/2003CA2478194A1 Continuous sulfatase inhibiting progestogen hormone replacement therapy
09/25/2003CA2477832A1 Methods of treating diabetes using pde 11a inhibitors
09/25/2003CA2476746A1 Difurylglycolic acid tropenol esters used as anticholinesterase drugs
09/24/2003EP1347042A1 A virus which can express tumor angiostatin factor with high efficiency in specific tumor cells and the use of it
09/24/2003EP1346745A1 Apparatus for treatment of tumor in the central nervous system (CNS)
09/24/2003EP1346730A1 Pretargeting methods and novel pretargeting conjugates
09/24/2003EP1346228A2 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
09/24/2003EP1346226A1 Screening method based on siah-numb interaction
09/24/2003EP1346221A1 A method of assaying for agonists or antagonist of dynorphin a binding to the mas receptor
09/24/2003EP1346061A2 Pregnancy-associated plasma protein-a2 (papp-a2)
09/24/2003EP1346059A1 Photochemical internalization for delivery of molecules into the cytosol
09/24/2003EP1346058A2 Adenoviral systems and the uses thereof
09/24/2003EP1346055A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
09/24/2003EP1346051A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
09/24/2003EP1346042A2 Fat regulated genes, uses thereof, and compounds for modulating same
09/24/2003EP1346041A2 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
09/24/2003EP1346033A2 Novel serine protease genes related to dppiv
09/24/2003EP1346031A2 Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof
09/24/2003EP1345965A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
09/24/2003EP1345960A2 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau-r4
09/24/2003EP1345956A2 Intracellular delivery of biological effectors by novel transporter peptide sequences
09/24/2003EP1345937A1 Quinuclidine carbamate derivatives and their use as m3 antagonists
09/24/2003EP1345932A1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
09/24/2003EP1345929A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345928A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345927A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345926A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345925A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345922A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345918A1 Chemical compounds
09/24/2003EP1345895A1 Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism
09/24/2003EP1345891A1 Glucagon antagonist/inverse agonist
09/24/2003EP1345890A1 Glucagon antagonists/inverse agonists
09/24/2003EP1345626A2 Novel pharmaceutical compositions based on anticholinergic agents and dopamine agonists
09/24/2003EP1345624A1 Induction of tolerance
09/24/2003EP1345618A2 Use of intermediate-conductance potassium channels and modulators for the diagnosis and treatment of illnesses having disturbed keratinocyte activity
09/24/2003EP1345617A2 Methods of modulating toll-related receptor (trr) signaling
09/24/2003EP1345611A1 An antibiotic/analgesic formulation and a method of making this formulation
09/24/2003EP1345608A2 The use of selective dopamine d4 receptor agonists for treating sexual dysfunction
09/24/2003EP1345607A1 Therapeutic combination of amlodipine and benazepril / benazeprilat
09/24/2003EP1345598A2 The use of ppar-gamma agonists for treating diseases characterised by neuron degeneration, neuron injury or impaired plasticity
09/24/2003EP1345574A2 Improvement of graft acceptance through manipulation of thymic regeneration
09/24/2003EP1345568A2 Stable skin conditioning compositions containing retinoid boosters
09/24/2003EP1345502A1 Creatine/citric acid compound, method for the production of the same and the use thereof
09/24/2003EP1345501A1 Nutritional and therapeutical preparations having antioxidant activity
09/24/2003EP1268482B1 Pyranoindoles for treating glaucoma
09/24/2003EP1100480B1 Muscarinic antagonists in the treatment of presbyopia
09/24/2003EP1080055B1 24-hydroxyvitamin d, analogs and uses thereof
09/24/2003EP0985032B1 Ribosome complexes as selection particles for in vitro display and evolution of proteins
09/24/2003EP0984959B1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
09/24/2003EP0982988B1 Substantially pure zonulin, a physiological modulator of mammalian tight junctions
09/24/2003EP0975359B1 Use of compounds binding a cytoplasmic dipeptidase for the potentiation of the immune response
09/24/2003EP0946190B1 Methods and compositions for stimulating neurite outgrowth
09/24/2003CN1444601A Regulating lipid levels via the Zmaxl or HBM gene
09/24/2003CN1444584A N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases
09/24/2003CN1444573A Carboxamide compounds and their use as antagonists of human 11CBY receptor
09/24/2003CN1444567A 咪唑衍生物 Imidazole derivatives
09/24/2003CN1444563A Quinoline and quinazoline derivatives
09/24/2003CN1444496A New use of lipase inhibitors
09/24/2003CN1444495A New pharmaceutical composition
09/24/2003CN1444488A Use and improvement of honey in wound dressings
09/24/2003CN1444486A Use of interferon receptor 2c polypeptide chain to enhance anti-growth effects of type I interferons
1 ... 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 ... 1151